Tag: Biological Therapy

Finance

Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done

02/23/2023
Bitcoin Ethereum News

An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...

Finance

It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

01/06/2023
Bitcoin Ethereum News

My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...

Finance

Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success

09/18/2022
Bitcoin Ethereum News

Text size Intellia CEO John Leonard called the results a vindication of the company’s modular approach to Crispr therapies. Courtesy Intellia Therapeutics Patients who got a one-time gene-editin...

Finance

Pfizer, Moderna Take Different Paths as Vaccine Boom Ends

08/11/2022
Bitcoin Ethereum News

Pfizer is trying to add $25 billion to its 2030 revenue through acquisitions. Dan Kitwood – WPA Pool/Getty Images Text size Pfizer ’s $5.4 billion deal to acquire the biotech Global Blood Therap...

Finance

Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

08/05/2022
Bitcoin Ethereum News

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...

Finance

Five Beaten-Up Biotech Stocks Saw Big Share Purchases

06/12/2022
Bitcoin Ethereum News

Text size Biotech stocks Kymera, Cullinan Oncology, Repare, Iovance, and Kodiak Sciences are all in the red so far this year, but they’ve seen large stock buys. Dreamstime Biotech stocks have taken so...